NOS3 as a potential modifier of ADPKD phenotypic variability: progress towards an answer

Affiliations

¹ Department of Renal Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; CKD.QLD and Centre for Kidney Disease Research, School of Medicine, University of Queensland, Brisbane, Queensland, Australia.

Editorial

Andrew Mallett et al. Nephrology (Carlton). 2014 Dec.

. 2014 Dec;19(12):733-4.

doi: 10.1111/nep.12331.

¹ Department of Renal Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; CKD.QLD and Centre for Kidney Disease Research, School of Medicine, University of Queensland, Brisbane, Queensland, Australia.

No abstract available

Comment on

NOS3 tagSNPs does not modify the chronic kidney disease progression in autosomal dominant polycystic kidney disease.
Ramanathan G, Periyasamy S, Lakkakula BV. Ramanathan G, et al. Nephrology (Carlton). 2014 Sep;19(9):537-41. doi: 10.1111/nep.12278. Nephrology (Carlton). 2014. PMID: 24824375
Effects of endothelial nitric oxide synthase gene on end stage renal disease progression in autosomal dominant polycystic kidney disease.
Xue C, Zhou CC, Sun LJ, He LL, Xu CG, Dai B, Mei CL. Xue C, et al. Nephrology (Carlton). 2014 Oct;19(10):630-7. doi: 10.1111/nep.12310. Nephrology (Carlton). 2014. PMID: 24995932 Review.